- Home
- INKT vs ANEB Comparison
INKT vs ANEB Comparison
Compare INKT & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- ANEB
- Stock Information
- Founded
- INKT 2017
- ANEB 2020
- Country
- INKT United States
- ANEB United States
- Employees
- INKT N/A
- ANEB N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- INKT Health Care
- ANEB Health Care
- Exchange
- INKT Nasdaq
- ANEB Nasdaq
- Market Cap
- INKT 36.7M
- ANEB 36.7M
- IPO Year
- INKT 2021
- ANEB 2021
- Fundamental
- Price
- INKT $7.98
- ANEB $1.43
- Analyst Decision
- INKT Strong Buy
- ANEB Buy
- Analyst Count
- INKT 2
- ANEB 1
- Target Price
- INKT $19.50
- ANEB $8.00
- AVG Volume (30 Days)
- INKT 9.9K
- ANEB 25.7K
- Earning Date
- INKT 03-18-2025
- ANEB 02-14-2025
- Dividend Yield
- INKT N/A
- ANEB N/A
- EPS Growth
- INKT N/A
- ANEB N/A
- EPS
- INKT N/A
- ANEB N/A
- Revenue
- INKT N/A
- ANEB N/A
- Revenue This Year
- INKT N/A
- ANEB N/A
- Revenue Next Year
- INKT N/A
- ANEB N/A
- P/E Ratio
- INKT N/A
- ANEB N/A
- Revenue Growth
- INKT N/A
- ANEB N/A
- 52 Week Low
- INKT $4.56
- ANEB $0.80
- 52 Week High
- INKT $19.00
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- INKT 43.30
- ANEB 58.07
- Support Level
- INKT $7.90
- ANEB $0.91
- Resistance Level
- INKT $8.88
- ANEB $1.70
- Average True Range (ATR)
- INKT 0.86
- ANEB 0.19
- MACD
- INKT -0.18
- ANEB 0.04
- Stochastic Oscillator
- INKT 9.87
- ANEB 65.91
Stock Price Comparison Chart: INKT vs ANEB
■ INKT
■ ANEB
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.